Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
Date:1/18/2011

oducts of high therapeutic value for human and veterinary medicine. In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment Prescription Medicines on research and development. For more information please visit www.boehringer-ingelheim.com.

Forward-Looking StatementsThis news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2009, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.  

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign) and difficulties or delays in manufacturing our products.  In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement.  Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
2. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
3. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
4. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DARTâ„¢-Based Antibody Therapeutics
6. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
7. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
10. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
11. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Deutschland, 31. Juli 2014  invendo medical ... („robotischen") Koloskopie-Systems für den Einmalgebrauch, verkündete heute, ... weltweit anerkannter Manager im Bereich Medizintechnik, als ... stößt. Logo - ... hochangesehener globaler Visionär der Medizintechnikbranche. Er war ...
(Date:7/31/2014)... , July 31, 2014  Celsion Corporation (NASDAQ: ... host a conference call to discuss its second quarter ... August 7, 2014. To participate in the call, interested ... ) or 1-785-830-1924 (International/Toll) and ask for the Celsion ... to register ten minutes before the call is scheduled ...
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
Breaking Medicine Technology:invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32
... 2011 Reportlinker.com announces that a new ... catalogue: The Changing Role ... http://www.reportlinker.com/p0574968/The-Changing-Role-of-Natural-Products-in-Drug-Discovery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development ... reveals how natural products have been of ...
... LOS ANGELES, July 18, 2011 The transformative power of ... were first introduced in the market. When cosmetic laser treatments ... of skin off the face to reveal smoother, younger skin ... that they could only work from the top of the ...
Cached Medicine Technology:The Changing Role of Natural Products in Drug Discovery 2The Changing Role of Natural Products in Drug Discovery 3The Changing Role of Natural Products in Drug Discovery 4Renaissance Laser and Vein Institute Specializes in Revolutionary Laser Treatments for a Variety of Cosmetic Applications 2
(Date:7/31/2014)... CAMBRIDGE, Mass. (July 31, 2014) Long associated ... ancient cellular survival response regulated by Heat-Shock Factor ... their environment into co-conspirators that support malignant progression ... Institute scientists this week in the journal ... with significant implications for the diagnosis, prognosis, and ...
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... Market Research, "Orthopedic Trauma Fixation Devices Market - Global ... - 2020," the global orthopedic trauma fixation devices market ... is expected to grow at a CAGR of 7.2% ... of USD 9.3 billion in 2020. Globally, the orthopedic ...
(Date:7/31/2014)... This news release is available in German ... The insular cortex is an integral "hub", combining ... in insular structure and function have been reported ... depression, addiction and autism spectrum disorders (ASD). Scientists ... Neurobiology in Martinsried now describe consistent alterations in ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... the colorants market in North America with analysis ... the TOC of the North American Colorants Market ... analysis provided. This also provides a glimpse of ... and is supported by various tables and figures. ...
(Date:7/31/2014)... virus that causes cold sores -- herpes simplex type 1 ... to a new study. Researchers in Australia found ... with the virus. This explains why some people with the ... only occasionally. The authors said the findings could lead to ... the disease was dormant, it was a truce. It turns ...
Breaking Medicine News(10 mins):Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 2Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 3Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 2Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 3Health News:Insular cortex alterations in mouse models of autism 2Health News:Insular cortex alterations in mouse models of autism 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2
... abnormal brain activity, researchers say , THURSDAY, Feb. 18 ... illness known as generalized anxiety disorder, a new study ... ways. , The study authors say the research ... suffering from debilitating anxiety. , "Patients experience anxiety ...
... ... Centers for Knee and Hip Replacement are part of the Blue Cross and Blue Shield ... ... has designated Abington Memorial Hospital as a Blue Distinction Center for Spine Surgery ...
... ... his new Authentic/Biblica book, Talking Smack , ... (PRWEB) February 18, 2010 -- Are you talking smack? You’d better be., , ... who has worked with parents and teens for more than 20 years and created the ...
... ... to begin an online journey, find the right ways to embrace this new communication environment ... ... of change for communicators everywhere. After a devastating recession in 2009, this year has ...
... ... delivery errors while protecting patients and caregivers. , ... Ferndale, MI (PRWEB) Feb. 18, 2010 ... of the Enovate Medication Cart, the newest addition to its medical cart series. ...
... ... (PCBs) and PCB engineering and design services, announces the availability of specialized PCBs for ... develop medical electronic printed circuit assemblies. , ... Chicago, IL (PRWEB) February 18, 2010 -- Electronic ...
Cached Medicine News:Health News:Anxiety Disorder Patients Process Emotions Differently 2Health News:Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM) 2Health News:Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM) 3Health News:Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM) 4Health News:Talking Smack to Keep Kids Drug-Free 2Health News:Talking Smack to Keep Kids Drug-Free 3Health News:Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters 2Health News:Enovate Announces New Lightweight Medication Cart Series 2Health News:Enovate Announces New Lightweight Medication Cart Series 3Health News:Electronic Interconnect Offers Medical Electronics, PCBs, Design Engineering 2Health News:Electronic Interconnect Offers Medical Electronics, PCBs, Design Engineering 3
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Jerome Halo Traction Units provide optimum immobilization for unstable injuries of the spine. The Generation 80 superstructure is available with either 2-point (serrated disk), or 3-point (flexion/ex...
... Boston Scoliosis Brace™ for neuromuscular ... a lightweight, soft, and easy ... maximum comfort. The Soft ... of non-cracking orthopedic grade copolymer ...
An indirect immunofluorescence antibody test for the qualitative and semi-quantitative detection of endomysial antibodies (EMA) in human serum as an aid in the diagnosis of celiac disease and dermati...
Medicine Products: